Clinical Predictors of Short Term Outcomes of Ablation of Idiopathic Monomorphic PVCs

Launched by ASSIUT UNIVERSITY · Jun 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how certain factors may predict the success of a procedure called ablation for patients with a type of heart rhythm problem known as idiopathic monomorphic PVCs (premature ventricular contractions). Essentially, the trial aims to identify which patients are more likely to benefit from this treatment. Ablation is a procedure that helps correct irregular heartbeats by targeting the areas of the heart that are causing them.

To be eligible for this trial, participants need to have idiopathic monomorphic PVCs, which means their heart is having extra beats but there is no underlying heart disease causing it. Unfortunately, patients with heart failure cannot participate. Those who join the study can expect to undergo evaluations and monitoring during the trial to see how well the ablation works for them. This research is important because it may help doctors understand which patients are most likely to experience positive outcomes from this treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients with idiopathic monomorphic PVCs
• Exclusion Criteria:
• • patients with heart failure